JAMA Psychiatry:25万越南退伍老兵遭受创伤后应激障碍(PTSD)困扰

2015-07-25 MedSci MedSci原创

在纽约大学蓝贡医学中心的Charles Marmar博士和他的同事们估计,大约15-17%的越南退伍军人在人生的某一时段会存在创伤后应激障碍(PTSD)。作者推断,估计目前有271000名越南退伍军人存在PTSD,其中有三分之一的人有抑郁症。作者的“越南老兵纵向研究”建立在全国越战老兵调整研究(NVVRS)的基础上(这项研究从1984年开始至1988年结束)。在对1839名越南老兵进行的原创性研究

在纽约大学蓝贡医学中心的Charles Marmar博士和他的同事们估计,大约15-17%的越南退伍军人在人生的某一时段会存在创伤后应激障碍(PTSD)。作者推断,估计目前有271000名越南退伍军人存在PTSD,其中有三分之一的人有抑郁症。


为了确定创伤应激障碍的流行率、进程和并发症,研究人员对NVVLS进行分析。NVVLS包括了一个自我报道的健康调查文件(n=1409),一个计算机辅助的电话调查健康采访(n=1279)以及一个电话临床采访(n=400)。受采访者均是越战老兵。这些调查在2012年7月3日到2013年5月17日间开展。共有2348名NVVRS参与者,1920人在NVVLS开始时仍然健在,81人在召集阶段去世。在剩下的1839人中有1450人(占78.8%)参与了至少一项NVVLS研究阶段。研究的指标包括了密西西比战争相关PTSD度量、DSM-ⅣPTSD清单(补充了PCL-5+)、临床执行的Y用于DSM-5(CAPS-5)的PTSD度量等。在男性越战老兵中,基于CAPS-5条件进行当下PTSD诊断的流行率为4.5%;基于CAPS-5的估计值为10.8%;基于PCL-5+条件的估计值为11.2%。而在女性老兵中,这三个值分别为6.1%、8.7%和6.6%。患有战区PTSD的老兵中有36.7%也患有重度抑郁症。

在越战结束四十几年后的今天,大约271000名越战老兵有着PTSD,其中三分之一有着重度抑郁症。这些研究仍然低估了患有PTSD老兵对心理健康服务的需求。由此可见,战争对于士兵的伤害远非肉体上的伤痛,更有心灵上的持久的伤痛。

作者的“越南老兵纵向研究”建立在全国越战老兵调整研究(NVVRS)的基础上(这项研究从1984年开始至1988年结束)。

在对1839名越南老兵进行的原创性研究中,有1450名退伍军人(78.8%)参加了新研究(从2012年7月到2013年5月)的至少一个时段。

战争地区的男性退伍军人诊断为PTSD的几率随定义不同而不同:以创伤后应激障碍量表(医生指南)第五版的《精神疾病诊断与统计手册”(“DSM-5”)为标准诊断病人患PTSD的发病率为4.5%;若添加一些诊断标准阈值下的PTSD(符合某些诊断标准),则患病率为10.8%;若以PTSD检查列表为基础并依据DSM-5检查项目对战争地区的退伍老兵进行诊断,则患病率为11.2%。其中女退伍军人的患病率分别为:6.1%、8.7%和6.6%。

在存在战争区PTSD的退伍老兵而言,有36.7%出现了明显的抑郁症状。约16%的战争区越南退伍军人PTSD得分增加了20分;约7.6%退伍军人PTSD得分下降了20分。之后,作者发现,大多数越南退伍军人在40年后仍会存在相应临床表现,且人数是症状改善的退伍军人的2倍多。

Charles Hoge博士认为,“对NVVRS队列研究的参与人员在战争结束40年后进行了认真而又详尽的随访,这为研究老人身体和心理状况提供了独特的视角。没有其他的研究可以达到这个纵向研究所能获取的的信息质量。发人深省的结果告诉我们越南战争对退伍老兵的身体和心理影响有多大,甚至世代都会受到其影响。该研究对抗战老兵及其后代至关重要,我们需要对PTSD患者提供医疗服务,以满足其需求,治疗退伍老兵存在的身体并发症和合并症。”

原始出处:

Marmar CR, Schlenger W, Henn-Haase C, Qian M, Purchia E, Li M, Corry N, Williams CS, Ho CL, Horesh D, Karstoft KI, Shalev A, Kulka RA. Course of Posttraumatic Stress Disorder 40 Years After the Vietnam War: Findings From the National Vietnam Veterans Longitudinal Study. JAMA Psychiatry. 2015 Jul 22. doi: 10.1001/jamapsychiatry.2015.0803

小知识:创伤后应激障碍( PTSD)

创伤后应激障碍( PTSD)是指个体经历、目睹或遭遇到一个或多个涉及自身或他人的实际死亡,或受到死亡的威胁,或严重的受伤,或躯体完整性受到威胁后,所导致的个体延迟出现和持续存在的精神障碍。PTSD的发病率报道不一,女性比男性更易发展为PTSD。

PTSD的发生与很多因素相关联,这些因素主要分为家庭、社会心理因素(如性别、年龄、种族、婚姻状况、经济状况、社会地位、工作状况、受教育水平、应激性生活事件、个性特征、防御方式、童年期创伤、家庭暴力、战争、社会支持等)和生物学因素(如遗传因素、神经内分泌因素、神经生化因素等)。其中重大创伤性事件是PTSD发病的基本条件,具有极大的不可预期性。
依据DSM-Ⅳ-TR,PTSD的诊断标准如下:
1.标准A
该个体曾经暴露于同时具备以下两点的创伤性事件:①A1 此人经历、目睹或者遭遇到一个或多个涉及自身或者他人的实际死亡,或者受到死亡的威胁,或严重的受伤,或躯体完整性受到威胁。②A2 此人的反应包括强烈的恐惧、无助或惊恐。注意:在儿童,可能表现为混乱或激惹性的行为。
2.标准B
创伤性事件在如下一个(或多个)方面持续性地重新体验:①B1 反复,插入性的对事件的苦恼记忆,包括图像、想法或者感知。注意:在年幼儿童,重复性的游戏中可以出现创伤事件的某些主题或者方面。②B2 反复的有关事件的苦恼的梦。注意:在儿童,可能出现令人惊恐的梦,但是没有可辨识的内容。③B3 表现得或感觉到好像创伤性事件重现了(包括再体验创伤经历、错觉、幻觉、分离性闪回事件,包括发生在清醒或中毒状态)。注意:年幼儿童中,可能会出现创伤特异性的重演。④B4当暴露在象征着创伤性事件的某些方面或者跟创伤性事件某些方面相似的内在或者内在的提示时,强烈的心理苦恼。⑤B5 当暴露在象征着创伤性事件的某些方面或者与创伤性事件某些方面相似的内在或者内在的提示时的生理反应。
3.标准C
对此创伤伴有的刺激作持久的回避,对一般事物的反应显得麻木(在创伤前不存在这种情况),如下列之3项以上:①C1 回避与创伤相关的想法,感觉或者对话的努力。②C2 回避会促使回忆起此创伤的活动、地点或人物。③C3 无法回忆此创伤的重要方面。④C4 对重要活动的兴趣或者参与明显降低。⑤C5 与他人疏远隔离的感觉。⑥C6 情感受限(如无法拥有爱的感觉)。⑦C7 未来缩短的感觉(如不期望能有一份职业、婚姻、孩子或者正常的人生)。
4.标准D
警觉性增高的症状(在创伤前不存在),表现为下列2项或以上:①D1 难以入睡,或睡眠困难。②D2 激惹或易发怒。③D3注意力集中困难。④D4 过度警觉。⑤D5 过分的惊吓反应。
5.标准E
上述障碍(B、C及D的症状)持续时间超过1个月。
6.标准F
这些障碍导致了临床上明显的苦恼,或在社交、职业或其他重要方面的功能受损。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
    2015-10-12 hlycom3356

    这篇文章写的很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
    2015-10-12 hlycom3356

    这篇文章写的很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
    2015-10-12 hlycom3356

    这篇文章写的很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
    2015-08-06 hlycom3356

    期待有更多研究

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1791926, encodeId=f50c1e9192660, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Dec 23 13:25:00 CST 2015, time=2015-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38557, encodeId=1f773855eec, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38558, encodeId=9f873855882, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=38559, encodeId=1b74385596e, content=这篇文章写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Mon Oct 12 13:24:00 CST 2015, time=2015-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35115, encodeId=d63d3511543, content=期待有更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 23:13:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335079, encodeId=c33413350e9fd, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445107, encodeId=051a144510e5b, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Jul 27 13:25:00 CST 2015, time=2015-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33532, encodeId=2f5e33532a7, content=战争后遗症, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 26 21:41:00 CST 2015, time=2015-07-26, status=1, ipAttribution=)]
    2015-07-26 午夜星河

    战争后遗症

    0

相关资讯

COP:创伤骨科手术感染的研究进展

通过了解相关的临床症状、体征和诊断方法,可以减少骨科伤口感染带来的并发症和死亡率。来自Scottsdale Healthcare Level 1 Trauma Center, Scottsdale, AZ的Gil R. Ortega等通过对最新文献的回顾,旨在帮助骨科医生对骨科伤口感染的诊断和治疗有个更充分的了解,原文发表于Current Orthopaedic Practice 2014

创伤后应激紊乱与癌症并无显著关联

近日,来自波士顿大学医学中心的研究人员在国际学术期刊european journal of epidemiology发表了一篇最新文章,他们进行了一项大型人群调查研究,对创伤后应激障碍( PTSD)是否是癌症风险因子这一问题进行了探究,结果与之前大量研究一致,PTSD与癌症之间不存在关联性。   这项研究与其他基于人群的调查研究结果一致,应激性事件与癌症发生无关联性,但这项研究除

病例:创伤股骨头脱位进入阴囊一例

近日,新英格兰杂志收录一例创伤性股骨头错位进入阴囊的病例。 一名33岁男性患者因摩托车车祸被送入急诊。相关检查提示阴囊坚硬、肿胀、淤青;左腿外旋伴轻度缩短。盆腔 CT 检查显示左髋关节脱位,左侧股骨近端转子处 3 处骨折(图 A 白色箭头),伴股骨头、股骨颈阴囊移位(图 A、B 黄色箭头);同时骨盆环左前侧及髋臼骨折(图 A、B 蓝色箭头),右侧前臂及手部开放性骨折。  &n

高迁移族蛋白B1在创伤中的研究进展

高迁移族蛋白(HMG)最早由Johns于20世纪70年代在小牛胸腺中发现,因其相对分子量小(25000-30000),在PAGE电泳迁移速度快而得名,而HMGB-1是其主要家族成员之一。近年来,HMGB-1因在病理状态下具有促炎作用而备受关注。目前,HMGB-1已被报道广泛参与脓毒血症、关节炎、胰腺炎、自身免疫性疾病、肿瘤、器官纤维化等多种疾病的发生和发展,然其在创伤中的作用却未被系统阐述。现

AHA 2014:血管加压素治疗心搏骤停和创伤 可行?

AHA科学年会复苏科学座谈会上的辩论显示,目前仍需更多研究以确定在心搏骤停或严重创伤患者复苏中应用血管加压素的利弊。 现有证据不足 多伦多大学Morrison教授表示,未来需要确定肾上腺素在心搏骤停中的最佳剂量和应用时机,哪些患者可从血管加压素中获益,以及快速推注和持续输注的选择。尽管一些研究显示肾上腺素可有有益于心搏骤停患者复苏,但仅有的一项肾上腺素与安慰剂随机对照试验并未得

AHA 2014:创伤和心搏骤停的挽救治疗进展

挽救治疗包括主动脉血流阻断、体外膜式氧合(ECMO)和体外生命支持(ECLS),并被用于标准治疗失败心跳骤停和创伤患者的复苏。AHA 2014复苏科学座谈会与会专家对何时以及如何应用挽救治疗进行了探讨。 美国布鲁克陆军医学中心Berry博士表示,对出血性休克应用挽救治疗时,穿透伤和钝伤患者的生存率分别为7%和1%,并且生存者中有15%伴有神经功能缺损。同时他认为,血管内球囊主动脉闭塞(R